Device Week, April 26, 2019 – Paragonix Launches Cardiac Organ Transport Device

In this edition of Device Week, Medtech Insight's Reed Miller chats with Marion Webb about her Start-Up Spotlight feature on Paragonix Technologies, which hopes to replace conventional organ transportation with its newly launched SherpaPak system. Reed Miller discusses the impact of Boston Scientific's entry into the US TAVR market after the US FDA approved its Lotus Edge TAVR system. Listen to the podcast via the player below: For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Medtech Insight articles addressing topics discussed in this episode: Boston Scientific Becomes Third US TAVR Competitor With Lotus Edge Approval Transcatheter Systems Set To Dominate Heart Valve Market Start-Up Spotlight: Paragonix Wants To Put 'More Heart' Into Transporting Organs